# Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets

> **NCT00413556** · PHASE3 · COMPLETED · sponsor: **ALK-Abelló A/S** · enrollment: 76 (actual)

## Conditions studied

- Allergy

## Interventions

- **BIOLOGICAL:** ALK Grass tablet

## Key facts

- **NCT ID:** NCT00413556
- **Lead sponsor:** ALK-Abelló A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-08
- **Final completion:** 2007-12
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2008-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413556, "Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00413556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*